DE602006020838D1 - Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum - Google Patents
Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikumInfo
- Publication number
- DE602006020838D1 DE602006020838D1 DE602006020838T DE602006020838T DE602006020838D1 DE 602006020838 D1 DE602006020838 D1 DE 602006020838D1 DE 602006020838 T DE602006020838 T DE 602006020838T DE 602006020838 T DE602006020838 T DE 602006020838T DE 602006020838 D1 DE602006020838 D1 DE 602006020838D1
- Authority
- DE
- Germany
- Prior art keywords
- medicaments
- heart failure
- anticholinergicum
- preventing
- treating heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64801205P | 2005-01-28 | 2005-01-28 | |
| PCT/EP2006/050408 WO2006079625A2 (en) | 2005-01-28 | 2006-01-24 | Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006020838D1 true DE602006020838D1 (de) | 2011-05-05 |
Family
ID=36129748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006020838T Expired - Lifetime DE602006020838D1 (de) | 2005-01-28 | 2006-01-24 | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7923455B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1843764B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2008528547A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE502637T1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2594693A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE602006020838D1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2362365T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2006079625A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060287347A1 (en) * | 2005-06-21 | 2006-12-21 | Aberg A K G | Methods for treating smooth muscle disorders using trospium |
| US20070004766A1 (en) * | 2005-07-01 | 2007-01-04 | Aberg A K G | Methods for relaxation of smooth muscle contractions using Trospium |
| WO2007017436A2 (en) * | 2005-08-08 | 2007-02-15 | Boehringer Ingelheim International Gmbh | Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
| JO3510B1 (ar) | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
| CZ2014188A3 (cs) | 2014-03-26 | 2015-10-07 | Zentiva, K.S. | Nové formy aclidinium chloridu a způsob jejich přípravy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002096422A2 (en) * | 2001-05-25 | 2002-12-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| CA2487399A1 (en) * | 2002-06-12 | 2004-02-19 | Epigenesis Pharmaceuticals, Inc. | Combination of anti-muscarinic agents and non-glucocorticoid steroids |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| US20050239778A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
| EP1781298B1 (de) * | 2004-04-22 | 2012-01-04 | Boehringer Ingelheim International GmbH | Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen |
-
2006
- 2006-01-13 US US11/332,646 patent/US7923455B2/en active Active
- 2006-01-24 CA CA002594693A patent/CA2594693A1/en not_active Abandoned
- 2006-01-24 DE DE602006020838T patent/DE602006020838D1/de not_active Expired - Lifetime
- 2006-01-24 EP EP06704250A patent/EP1843764B1/en not_active Expired - Lifetime
- 2006-01-24 WO PCT/EP2006/050408 patent/WO2006079625A2/en not_active Ceased
- 2006-01-24 AT AT06704250T patent/ATE502637T1/de active
- 2006-01-24 JP JP2007552632A patent/JP2008528547A/ja active Pending
- 2006-01-24 ES ES06704250T patent/ES2362365T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006079625A3 (en) | 2007-07-26 |
| EP1843764B1 (en) | 2011-03-23 |
| US20060173038A1 (en) | 2006-08-03 |
| EP1843764A2 (en) | 2007-10-17 |
| WO2006079625A2 (en) | 2006-08-03 |
| CA2594693A1 (en) | 2006-08-03 |
| ATE502637T1 (de) | 2011-04-15 |
| US7923455B2 (en) | 2011-04-12 |
| JP2008528547A (ja) | 2008-07-31 |
| ES2362365T3 (es) | 2011-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| CY1111478T1 (el) | Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης | |
| WO2004006906A3 (en) | Methods for the treatment of neoplasms | |
| ATE480255T1 (de) | Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen | |
| WO2004006842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| WO2003092617A3 (en) | Combinations for the treatment of inflammatory skin disorders | |
| PH12021553102A1 (en) | Methods of treating fabry disease in patients having renal impairment | |
| DE602004021847D1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| WO2022047128A3 (en) | Method for treating complement mediated disorders caused by betacoronaviruses | |
| WO2006098603A3 (en) | Composition comprising isoorientin for suppressing histamine | |
| WO2005070450A3 (de) | Verwendung von niedrig dosiertem erythropoietin zur behandlung von akuter oder chronischer niereninsuffizienz und zur behandlung von wunden | |
| WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| EA201000630A1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов в крови | |
| DE602004031631D1 (de) | Verwendung von betain zur behandlung von claudicatio intermittens | |
| WO2023240199A3 (en) | Fitusiran for the treatment of hemophilia a and b | |
| EA202193276A1 (ru) | Способы лечения холангиокарциномы | |
| ATE502637T1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| EP4209220A4 (en) | COMPOSITION FOR IMPROVING, PREVENTING OR TREATING MUSCLE ATROPHY OR SARCOPENIA, CONTAINING 2'-FL | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| EA202193211A1 (ru) | Лечение синуклеопатий | |
| WO2019232203A3 (en) | Methods and compositions to alleviate vascular permeability | |
| WO2008016665A3 (en) | Imidazoacridine compounds for treating flt3 -mediated disorders |